Compugen reported $2.38M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.38M 12K Jun/2025
Life Technologies USD 4.93M 1.34M Jun/2025
RedHill Biopharma USD 4.48M 1.52M Mar/2024